Skip to content
SUMMIT
European Cannabis Insights Summit 2026 — Exclusive industry intelligence
Register Now
EVENT
Cannabis Europa London 2026 — Europe's cannabis industry unites
Get Tickets
News
Global Cannabis News & Analysis | Business of Cannabis
Industry Trends
Explore long-term trends shaping the global cannabis economy, from legalisation to innovation.
Opinion
Read expert opinions and analysis on policy, markets, and culture in the cannabis industry.
Editorial Picks
Hand-picked stories offering depth, insight, and perspective on global cannabis developments.
Markets & Stocks
Stay informed about the latest developments and trends in the cannabis stock market with Business of Cannabis. Discover new investment opportunities, market analysis, and more in our stocks category.
M&A Tracker & News
Public Markets
Explore the top publicly listed cannabis firms and market trends driving global valuation.
Investment & Finance
Insight into funding rounds, venture capital, and financial strategy shaping cannabis growth.
Policy & Regulation
Stay informed about the latest cannabis regulation developments and changes with Business of Cannabis. Learn about new laws, policies and more.
UK & Europe
In-depth coverage of regulatory change and licensing frameworks across the UK & EU.
US & Canada
Analysis of federal and state cannabis reform shaping the North American market.
International Regulation
Country-by-country insight on legalisation models, trade rules, and compliance trends.
Legal Analysis
Expert commentary on cannabis law, IP, advertising, and risk management worldwide.
Medical
Stay up-to-date on the latest medical cannabis research, news, and information with Business of Cannabis. Learn about new treatments, laws, and more.
Medical Cannabis
Science-led insight on therapeutic use, formulations, and clinical best practice.
Patient Access
How patients obtain medical cannabis through licensed clinics and specialist prescribers.
Prescribers & Clinics
Resources and governance insight for clinicians and healthcare providers.
Pharmaceutical
Learn about the latest developments in the pharmaceutical cannabis industry with Business of Cannabis. Discover new drugs, research, and more.
CBD & Hemp
Data-driven coverage of CBD innovation, hemp policy, and wellness applications.
CBD Market
Stay informed about the latest trends and developments in the CBD industry with Business of Cannabis. Discover new products, industry insights, and more.
Hemp Industry
Explore the latest developments in the hemp industry with Business of Cannabis. Find out about new products, regulations, and more.
Products
What to look for in CBD oils, edibles, and supplements — testing, safety, and labelling.
Business
Intelligence for founders, operators, and investors building sustainable cannabis ventures.
Start-Ups
Entrepreneur stories, funding pathways, and lessons from emerging cannabis companies.
Retail & Brands
How leading cannabis retailers and brands design, market, and scale in regulated markets.
Cultivation
Supply Chain
Distribution, compliance, and efficiency trends powering cannabis supply networks.
Companies
Stay informed about the latest developments and news from cannabis companies with Business of Cannabis. Learn about new products, mergers and acquisitions, and more.
Press releases
Stay informed about the latest developments and official statements in the cannabis industry with Business of Cannabis’ collection of press releases. Learn about new products, industry news and more from top companies.
Interviews
Exclusive conversations with CEOs and founders defining the cannabis economy.
Intelligence
Research Repository
M&A Tracker
Stocks Tracker
Cannabis Rescheduling
EU Cannabis Regulation Hub
Cannabis Directory
Events
Stay informed about upcoming cannabis events and conferences with Business of Cannabis. Learn about new products, industry insights, and more.
European Cannabis Insights Summit 2026
BofC New York
Previous Events
Stay informed about upcoming cannabis events and conferences with Business of Cannabis. Learn about new products, industry insights, and more.
BofC Awards 2026
Cannabis Europa
Cannabis Health Symposium
BofC x MJ Berlin
More
Recent Searches
Popular Searches
Glass Pharms
medical
Medical Cannabis
Cannabis Health Symposium
Kanabo Calls in Administrators
Article
antiflamx near me abbotsford bc
teaching feeling scene
for driving licence test
LEADER AM
Search
Recent Searches
Popular Searches
Glass Pharms
medical
Medical Cannabis
Cannabis Health Symposium
Kanabo Calls in Administrators
Article
antiflamx near me abbotsford bc
teaching feeling scene
for driving licence test
LEADER AM
Search
News
Industry Trends
Opinion
Editorial Picks
Markets & Stocks
M&A Tracker & News
Public Markets
Investment & Finance
Policy & Regulation
UK & Europe
US & Canada
International Regulation
Legal Analysis
Medical
Medical Cannabis
Patient Access
Prescribers & Clinics
Pharmaceutical
CBD & Hemp
CBD Market
Hemp Industry
Products
Business
Start-Ups
Retail & Brands
Cultivation
Supply Chain
Companies
Press releases
Interviews
Intelligence
Research Repository
M&A Tracker
Stocks Tracker
Cannabis Rescheduling
EU Cannabis Regulation Hub
Cannabis Directory
Events
European Cannabis Insights Summit 2026
BofC New York
Previous Events
BofC Awards 2026
Cannabis Europa
Cannabis Health Symposium
BofC x MJ Berlin
Home
/
News
/
Opinion
Opinion archive
Filter By Year:
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
Sort News:
Oldest
Newest
Filter By Category:
Editorial Picks
Industry Trends
Latest News
Opinion
Adult-Use
Why Medical Companies Win Rescheduling, Whatever Happens to Adult-Use
By
BusinessOfCannabis
July 09, 2026
Opinion
Who Really Benefits from Britain’s Medical Cannabis System?
By
Saxon Coop
June 30, 2026
News
Is the US Hemp Ban Punishing the Wrong People?
By
Scott Mazza
June 22, 2026
Markets & Stocks
Cannabis at an Inflexion Point: A Structural Repricing Ahead
By
Sean Mclean
June 08, 2026
Opinion
Europe’s Medical Cannabis Market Has Grown Up, Now Its Supply Chain Needs To
By
Oskar Fletcher
June 04, 2026
Markets & Stocks
Cannabis at an Inflexion Point: Why Capital Is Missing the Opportunity
By
Sean Mclean
June 01, 2026
Opinion
From Green Success to BH Labs: Why the Next Cannabis Leaders Will Look More Like Technology Companies
By
BusinessOfCannabis
May 25, 2026
Opinion
DEA’s Schedule III Cannabis Order: A Free-For-All for Telehealth Platforms, or the Perfect Setup for the Entire Industry?
By
Deb Tharp
April 29, 2026
Medical
Is the ‘Commercial Scale’ of Medical Cannabis in the UK Inappropriate?
By
James Duckenfield
April 02, 2026
Markets & Stocks
Is a Cannabis M&A Tidal Wave on the Way?
By
Ben Stevens
March 13, 2026
Opinion
Rescheduling Will Reprice Medical IP, Not Retail Footprints
By
Stephen Murphy
March 11, 2026
Opinion
Organigram Acquires Sanity Group: When Big Tobacco Moves into Cannabis
By
Dr. Sebastian Marincolo
March 06, 2026
Opinion
US Cannabis Rescheduling: A Victory or a Federal Trap?
By
Deb Tharp
February 23, 2026
Industry Trends
AI: The Last Refuge of the Failed Cannabis Company
By
Ben Stevens
February 17, 2026
CBD & Hemp
Industry Leaders React to Historic Cannabis Rescheduling
By
Ben Stevens
December 19, 2025
Editorial Picks
Germany’s Hidden Stigma Crisis: Why Pillar 2 is Still Sorely Needed
By
Dr. Sebastian Marincolo
December 11, 2025
Companies
From Growth to Discipline: PHCANN’s Vision for Pharmaceutical Cannabis in Europe
By
Ben Stevens
October 13, 2025
Opinion
Trump Just Put Cannabinoids Back in the Spotlight — Science Might Finally Catch Up
By
Ben Stevens
October 01, 2025
